FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: CodeSystem/300000000002

Packageeu.epi.february2025
Resource TypeCodeSystem
Id300000000002
FHIR VersionR5
Sourcehttps://simplifier.net/resolve?scope=eu.epi.february2025@1.0.0&canonical=http://ema.europa.eu/fhir/CodeSystem/300000000002
URLhttp://ema.europa.eu/fhir/CodeSystem/300000000002
Version5.0.0
Statusactive
NameEUepiannexIIcodesystem
TitleEU EPI Annex II QRD code values
DescriptionEU EPI Annex II QRD code values
Contentcomplete

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

No narrative content found in resource


Source

{
  "resourceType": "CodeSystem",
  "status": "active",
  "content": "complete",
  "name": "EUepiannexIIcodesystem",
  "id": "300000000002",
  "title": "EU EPI Annex II QRD code values",
  "description": "EU EPI Annex II QRD code values",
  "version": "5.0.0",
  "url": "http://ema.europa.eu/fhir/CodeSystem/300000000002",
  "concept": [
    {
      "code": "000000000000",
      "display": "Code for custom sub-sections (reserved)"
    },
    {
      "code": "200000029850",
      "display": "ANNEX II"
    },
    {
      "code": "200000029851",
      "display": "A. <MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND> MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE"
    },
    {
      "code": "200000029852",
      "display": "B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE"
    },
    {
      "code": "200000029853",
      "display": "Official batch release"
    },
    {
      "code": "200000029854",
      "display": "C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION"
    },
    {
      "code": "200000029855",
      "display": "Periodic safety update reports (PSURs)"
    },
    {
      "code": "200000029856",
      "display": "D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT"
    },
    {
      "code": "200000029857",
      "display": "Risk management plan (RMP)"
    },
    {
      "code": "200000029858",
      "display": "Additional risk minimisation measures"
    },
    {
      "code": "200000029859",
      "display": "Obligation to conduct post-authorisation measures"
    },
    {
      "code": "200000029860",
      "display": "E. SPECIFIC OBLIGATION TO COMPLETE POST-AUTHORISATION MEASURES FOR <THE CONDITIONAL MARKETING AUTHORISATION> <THE MARKETING AUTHORISATION UNDER EXCEPTIONAL CIRCUMSTANCES"
    }
  ],
  "experimental": false,
  "publisher": "European Medicines Agency",
  "jurisdiction": [
    {
      "text": "European Union"
    }
  ],
  "caseSensitive": true,
  "count": 12
}